EUSA Pharma
Record number of health firms feature in UK top 100 private tech list
Richard Staines
Babylon Health, digital, EUSA Pharma, exscientia, Kymab
0 Comment
Taking lenient stance, NICE backs neuroblastoma drug
Richard Staines
dinutuximab alpha, EUSA Pharma, neuroblastoma, NICE
0 Comment
Body makes special case due to rarity of the disease
Cancer/ Market Access/ News/ News/ News/ News/ Oncology/ R&D
Fotivda approved in Scotland for kidney cancer
Market Access/ News/ News/ News/ Oncology
NICE asks EUSA pharma to drop price of neuroblastoma drug
Richard Staines
cancer, EUSA Pharma, market access, NICE, Rare diseases
0 Comment
NICE calls for price cut before possible CDF funding
EUSA Pharma’s Fotivda approved in EU for kidney cancer
Richard Staines
Bayer, cancer, EUSA Pharma, kidney cancer
0 Comment
UK pharma gets licence for second cancer drug
EUSA Pharma looks to further in-licensing to build growth
Richard Staines
cancer, EUSA Pharma, Jazz Pharmaceuticals, kidney cancer, neuroblastoma
0 Comment
Regulators finally back Merck KGaA oral MS drug
Richard Staines
AbbVie, cancer, EUSA Pharma, Gilead, hepatitis C, Merck KGaA, multiple sclerosis, Samsung Bioepis
0 Comment